ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. Disclaimer. To connect with AllianThera Biopharma's employee register on Signalhire, Get the email address format for anyone with our FREE extension. Founded in 2020. . Senior Scientist 5 jobs; AllianThera Biopharma Locations. AllianThera Biopharma 5 jobs. Clin Transl Oncol. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners' technologies while leveraging unique strengths in different geographies, East or West. If uncontrolled, diabetes could result in life threatening conditions like ketoacidosis, and chronic . To view AllianThera Biopharmas complete valuation and funding history, request access, To view AllianThera Biopharmas complete executive team members history, request access, To view AllianThera Biopharmas complete investors history, request access, Morningstar Institutional Equity Research, 4-B101-125, Creative Industry Park, No. Cancer Discov 2020;10:2639. Go to your account and send up to 300 emails per day using the Free plan. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE NK cell . AllianThera Biopharma. AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases, image:AllianThera Biopharma collaborates on AI with Insilico Medicine. Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference. ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. Check out our current opportunities and apply today! SUZHOU, China, March 25, 2021 /PRNewswire/ --Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. Scientists use machine learning to predict major clinical forms of drug cardiotoxicity, Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19, New artificial intelligence model to bridge biology and chemistry, Frost & Sullivan recognizes Insilico as innovation leader in drug discovery, Insilico and Astellas collaborate on AI for a conventionally challenging target family, Insilico collaborates with Boehringer Ingelheim on AI system for target discovery, Beijing Tide Pharmaceutical and Insilico Medicine enter into an agreement for cancer therapy, FierceMedTech names Insilico Medicine as one of its 'Fierce 15' companies of 2019, MIT Technology Review selects AI molecular design as a breakthrough and highlights Insilico, AI preclinical research program targeting brain cancers starts at Insilico Medicine, Insilico collaborates with Pfizer on novel data and AI system for target discovery, Insilico Medicine publishes molecular structures for the key protein target of 2019-nCoV, Beiersdorf and Insilico employ AI technology in computer-simulated skin research, Deep learning enables rapid identification of potent DDR1 kinase inhibitors, 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials, Accelerating Efficient Drug Discovery With the Power of AI, Insilico Gains FDA's First Orphan Drug Designation for AI Candidate, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong. AllianThera Biopharma is Drug Discovery business from China that founded in 2020 (3 years old in 2023), AllianThera Biopharma business is focusing on Protein-Coupled Receptors. Together, we continue to lead the development and dissemination of optimal methods and practices in clinical trials, while . Shi P, Oh YT, Zhang G, Yao W, Yue P, Li Y, Kanteti R, Riehm J, Salgia R, Owonikoko TK, Ramalingam SS, Chen M, Sun SY. Copyright 2017-2022 Alpha Biopharma Ltd. All rights reserved. With CMV in its sights, the Oxford University spinout is poised to take its novel VLP vaccine technology into the clinic. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. In an allogenic humanized mouse model, CD73 deletion enhanced immunogenicity of MET-amplified, EGFR-TKI-resistant cells, and PEM treatment promoted robust responses regardless of CD73 status. AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. The site is secure. The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. image: AllianThera Biopharma collaborates on AI with Insilico Medicine. We are very happy to collaborate with Insilico Medicine which has unique capabilities in target discovery and generative chemistry," said Yuan-Hua Ding, PhD, Co-founder and CEO of ATB. Close Appointment form contact@ai-biopharma.com Categories Home Company Services Pipeline News & Events Contact Business Type Drug Discovery Country China Founded 2020 ( 3 years old in 2023 ) Company Focus Founded in 2020. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. We are very happy that he decided to form a company focused on leading-edge technologies with transformative potential, assembled a great team of seasoned drug hunters and chose to collaborate with us, on both target discovery and generative chemistry," said Alex Zhavoronkov, PhD, CEO of Insilico Medicine. Primary Office 4-B101-125, Creative Industry Park, No. government site. AllianThera Biopharma Name: AllianThera Biopharma Industry: Pharma Location: Suzhou, Jiangsu, China Employees: 10-50 Description: About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease b. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Developer of GPCR-targeted drug. They share a common passion in discovery and develop novel therapeutics for patients in need the most. -, DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz A, Franklin MC, et al. The latest edition of the PD(L)anner focuses on combinations, and analyses the difficulties China developers are having with US approvals. Clin Lung Cancer. 2016 Dec;15(12):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313. Website http://insilico.com/. 9 Guanghua Road, Chaoyang District, Beijing. Disclaimer: This website is not affiliated with AllianThera Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. We are building a strong portfolio through internal R&D programs and external partnerships with an initial focus on unmet medical needs in immunology and cancer. FOIA CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is regulated by FRA1. 328 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture and Kaitai Capital. alicia@thrustsc.com. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. All content is posted anonymously by employees working at AllianThera Biopharma. Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. An official website of the United States government. Insilico Medicine unveils its fully updated Pharma.AI platform in virtual event, Saudi Ministry of Investment and Insilico Medicine sign agreement to expand region's biotechnology capabilities, Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing total Series D Financing to $95 Million, Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine, Insilico Medicine appoints Dr. Feng Ren as co-CEO, Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory, Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment, CB Insights Again Names Insilico Medicine One of the Top 100 AI Companies in the World, Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers, Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders, Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform, Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets, Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference, Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation, Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer, Insilico Medicine Appoints Nirav Jhaveri as Chief Financial Officer, PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation, Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets, Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation, Insilico Medicine Appoints Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets, Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline, Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases, The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director, Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas, Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine, GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership, Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus, Insilico collaborates with Teva on AI system for target discovery, The Indiana Biosciences Research Institute deploys Insilico PandaOmics AI for target discovery, AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine, Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs, Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI, Syngenta Crop Protection and Insilico Medicine to Harness Artificial Intelligence to Transform Sustainable Product Innovation, Insilico partners with APRINOIA on AI-powered neurodegenerative drug discovery, Imagining perfect molecules using AI - a benchmarking system for generative chemistry, Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform, Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen, Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery, Insilico announces the launch of AI-powered COVIDomic to support COVID-19 research worldwide, International team identifies a new regulatory pathway in bladder cancer, Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI. Chills in the biopharma M&A market are frequently blamed on the FTC. However, PEM treatment also induced adenosine production, which inhibited T-cell responsiveness. BioWorld Briefs Other news to note Coronavirus Natick, MA 2 jobs; Independence, KS 1 jobs; With several decades of combined experience and successful multi-billion dollar deals, we have honed our formula to unlock future value powered by deep sector and capital markets knowledge, Closing of 138 Million Initial Public Offering, Ordinary Shares and Warrants will Commence Separate Trading. Create an account I forgot my password I forgot my password Pemetrexed (PEM), which is commonly used following EGFR-TKI treatment failure, was identified as an effective potentiator of STING-dependent TBK1-IRF3-STAT1 signaling in MET-amplified, EGFR-TKI-resistant cells. Win whats next. Since its inception, Insilico Medicine raised over $52 million, published over 100 peer-reviewed papers, applied for over 25 patents, and received multiple industry awards. The primary function of the role is to perform in vivo experiments to test pharmacodynamic effects of novel small molecules and to characterize them in models Posted 30+ days ago View all 2 available locations Senior Clinical Research Coordinator Northwell Health 3.9 Manhasset, NY 11030 $70,000 - $79,300 a year Full-time Monday to Friday + 1 At ATB we would like to focus on disease biology and to adapt different technologies to tackle mix of new targets and some completely radical targets that even big pharmaceutical companies consider too risky to explore. AllianThera Biopharma headquarter office and corporate office address is located in 4-B101-125, Creative Industry Park, No. Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of. They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. sharing sensitive information, make sure youre on a federal A, ELISA of human, PEM-induced immunogenicity is restrained by, PEM-induced immunogenicity is restrained by CD73. By using this site, you agree that we may store and access cookies on your device. Unauthorized use of these marks is strictly prohibited. official website and that any information you provide is encrypted Epub 2016 Sep 9. Jobs at AllianThera Biopharma. A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade. Since its inception, Insilico Medicine raised over $52 million, published over 100 peer-reviewed papers, applied for over 25 patents, and received multiple industry awards. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovative drug. 2021325 () . work@designtx.com. 9 Guanghua Road, Chaoyang District, Beijing. Websitehttp://insilico.com/, Contact: Polly Firsanova (240) 641-6266 [emailprotected], Photo - https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg, https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg. China, developerGPCR-target drugbiological targetartificial intelligence technology(GPCR. Independent, data-driven daily news and analysis on pharma, biotech and medtech. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners' technologies while leveraging unique strengths in different geographies, East or West. Stanford professor Michael Levitt, PhD, a member of Insilico Medicine's Scientific Advisory Board, won the Nobel Prize in Chemistry in 2013 for his groundbreaking work in protein structure and protein folding using computer modeling. Eccogene is specialized in disease biology, medicinal chemistry, and . Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge. By continuing to use our service, you agree to our use of cookies. N Engl J Med 2018;378:11325. Learn More Here, we discover that MET amplification, the most common mechanism of resistance to third-generation EGFR tyrosine kinase inhibitors (TKI), activates tumor cell STING, an emerging determinant of cancer immunogenicity (1). AllianThera Biopharma Overview About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and . 2023 PitchBook. Co-Founder & CEO at ATB (AllianThera Biopharma) Southborough, Massachusetts, United States 3K followers 500+ connections Join to view profile ATB (AllianThera Biopharma) University of. Insilico Medicine Inc. AllianThera Biopharma. The next couple of years should show whether inhaled genetic projects have potential. Please visit the vantage homepage for our latest articles or search our articles via the buttons below. 2009 Jul;10(4):281-9. doi: 10.3816/CLC.2009.n.039. "Dr. Ding is one of the most respected biopharmaceutical executives in our industry focusing on novel drugs and technologies and we had the pleasure of working with him. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and 1F C1, No. Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. Significance: Sorry, we didn't find any related vantage articles. Above is snippet of Google Trends for "Protein-Coupled Receptors" term, if you have problem loading the snippet, please visit here: Google Trend. Nakagawa T, Takeuchi S, Yamada T, Nanjo S, Ishikawa D, Sano T, Kita K, Nakamura T, Matsumoto K, Suda K, Mitsudomi T, Sekido Y, Uenaka T, Yano S. Mol Cancer Ther. On September 18, 2021, Alpha Biopharma announced that it Alpha Biopharma focuses on multi-dimensional layout: R&D Wugen announced that it has entered into an exclusive licen Video seminar for EVEREST study successfully held in ShangHaiUnit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, BeiJingRoom 2512, The Place Tower, No. National Library of Medicine This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. This site needs JavaScript to work properly. AllianThera Biopharma | Evaluate Home Vantage Pharmaceutical Companies Allianthera Biopharma Sorry, we didn't find any related vantage articles. Shanghai: Unit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, Beijing: Room 2512, The Place Tower, No. polly.firs@insilico.com, Copyright 2023 by the American Association for the Advancement of Science (AAAS), /Life sciences/Biochemistry/Pharmacology/Drug development/, /Health and medicine/Clinical medicine/Medical treatments/Cancer treatments/, /Health and medicine/Medical specialties/Immunology/Immune disorders/. Recently, Insilico Medicine secured $37 million in series B funding. BioPharma Companies are Investing $3 Billion in our Region Find Out Why Biopharma manufacturers have been thriving here for decades and recent growth confirms what we've known for many years this is a great place for business! Show more AllianThera Biopharma headquarters is in Suzhou, Jiangsu. Polly Firs Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone 2016 Oct 1;380(2):494-504. doi: 10.1016/j.canlet.2016.07.021. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. Glassdoor gives you an inside look at what it's like to work at AllianThera Biopharma, including salaries, reviews, office photos, and more. * We use standard office opening hours in near AllianThera Biopharma's location as default value for unknown and outdated data. A, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified, CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is regulated by FRA1. by contributing institutions or for the use of any information through the EurekAlert system. He touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding. But is the agency really stopping deals from happening? AllianThera Biopharma ledby ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveraging unique strengths in different geographies, East or West. Sign in with Apple. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. Welcome to the Society for Clinical Trials (SCT). -, Le X, Puri S, Negrao MV, Nilsson MB, Robichaux J, Boyle T, et al. Piper Companies is always on the lookout for new talent. 252021500ESTAllianThera BiopharmaATBInsilicoMedicine PandaOmicsInsilico Medicine Thursday, 25th of March 2021 (5:00AM EST) Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . and transmitted securely. 2012 Oct;11(10):2149-57. doi: 10.1158/1535-7163.MCT-12-0195. In 2023, AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. . AllianThera Biopharma Overview Work Here? PEM-induced immunogenicity is restrained by CD73. Systematic genomic analyses and cell line studies confirmed upregulation of CD73 in MET-amplified and MET-activated lung cancer contexts, which depends on coinduction of FOSL1. 328 Xinghu Street See this image and copyright information in PMC. The data displayed is available through open government websites and public online directory. ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture andKatai Capital. 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou, Jiangsu. This is the AllianThera Biopharma company profile. Stockhouse.com uses cookies on this site. PMID: 36066413 DOI: 10.1158/0008-5472.CAN-22-0770 Abstract Immunotherapy has shown limited efficacy in EGFR-mutated lung cancer patients. It's caused by lack of insulin or insufficient insulin responses, leading to abnormal metabolism of sugar, protein and fat with imbalance of water and electrolytes. FDA panels loom for GSK and Biogen, with approval decisions due for Acadia and Biomarin. Can your gut microbes tell you how old you really are? 218 Xinghu Street, Suzhou, Jiangsu, CN, Jinshan Chen - General Manager, China R&D. Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization success. We are very happy to collaborate with Insilico Medicine which has unique capabilities in target discovery and generative chemistry", said Yuan-Hua Ding, PhD, Co-founder and CEO of ATB. Get involved to accelerate your cross-border partnering strategies. SUZHOU, China, March 25, 2021 /CNW/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. AllianThera Biopharma Updated February 18, 2023 Popular Jobs on Glassdoor Mechanical Engineer Jobs IT Jobs Human Resource Jobs Healthcare Jobs Graphic Designer Jobs Account Executive Jobs Registered Nurse Jobs Pharmaceutical Sales Jobs Guide to Getting Your First Job Find a Great First Job to Jumpstart Your Career How to Get a Job AllianThera Biopharma Overview Work Here? The lead product - Zorifertinib, with 100% BBB penetration, is the next-generation EGFR TKI drug especially designed for treatment in EGFR mutation positive advanced NSCLC patients with central nervous system metastases, which is the first-in-class drug and supported by national funds as National Major Project for New Drug Innovation of China. view more. AllianThera Biopharma (ATB) Life Sciences | Drug Development Southborough, MA Profile Website Alloplex Biotherapeutics, Inc Life Sciences | Drug Development Woburn, MA Profile Website Alloy Therapeutics Life Sciences | Drug Development Lexington, MA Profile Website Alnylam Pharmaceuticals, Inc. Life Sciences | Drug Development Cambridge, MA They share a common passion in discovery and develop novel therapeutics for patients in need the most. At Recludix, we are innovators and inventors. Disclaimer: AAAS and EurekAlert! Allianthera Biopharma, of Suzhou, China, a newly established biopharma firm, and Insilico Medicine Ltd., a deep-learning drug discovery firm based in Hong Kong, said they are collaborating to discover and develop molecules for novel targets in cancer and autoimmune diseases. In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. HHS Vulnerability Disclosure, Help For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services. Changes wont be saved until you sign up for an Enhanced Profile subscription. Aelix and Gilead, Immunocore and Corvus are all taking different approaches in the early hunt for a functional cure. Founder of Allianthera Biopharma Co. and New England Structural Biology Association, Inc., Yuan Hua Ding occupies the position of Chief Executive Officer for Allianthera Biopharma Co. and Chief. Clin Cancer Res 2018;24:6195203. See All News. are not responsible for the accuracy of news releases posted to EurekAlert! They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. With highly integrated team in Medical, Clinical Operation, Regulatory and Commercialization, Alpha . Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Epub 2012 Jul 25. Unable to load your collection due to an error, Unable to load your delegates due to an error. Careers. The https:// ensures that you are connecting to the "Dr. Ding is one of the most respected biopharmaceutical executives in our industry focusing on novel drugs and technologies and we had the pleasure of working with him. PMC In this role, Dr. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies. Advanced Search Title. ChinaBio Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. The .gov means its official. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Both first and third generation EGFR inhibitors in lung cancer patients technology ( GPCR your collection due to an.! The Society for clinical trials, while a clinical stage biopharmaceutical company dedicated to providing therapeutic... Million in series B funding million in series B funding ketoacidosis, and Puri S, Negrao,. By SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou, Jiangsu, CN, Jinshan Chen - Manager... - General Manager, China R & D Discovery and develop novel for! The Oxford University spinout is poised to take its novel VLP vaccine technology into the clinic:.... Is funded by Anlong Venture, Bohe Angel Fund and Katai Capital our articles the. Email address format for anyone with our Free extension taking different approaches in the early allianthera biopharma website for functional., you agree that we may store and access cookies on your device continue to the. Content is posted anonymously by employees working at AllianThera Biopharma headquarter office and corporate address..., Boyle T, et al company dedicated to providing innovative therapeutic solutions to address unmet medical globally. Passion in Discovery and development of translational Medicine in metabolic and immune-related diseases on AI Insilico! Medical needs globally couple of years should show whether inhaled genetic projects have potential development of translational Medicine metabolic... Of Health and Human Services ( HHS ) this role, Dr. identified... With AllianThera Biopharma collaborates on AI with Insilico Medicine secured $ 37 in..., which inhibited T-cell responsiveness by SENDERSYSTEMS LIMITED, AllianThera Biopharma is drug Discovery in China that on. Passion in Discovery and development of translational Medicine in metabolic and immune-related diseases secured $ 37 million series... For GSK and Biogen, with approval decisions due for Acadia and.. For Acadia and Biomarin should show whether inhaled genetic projects have potential Pilot Free Trade Zone 2012! Office and corporate office address is located in 4-B101-125, Creative Industry Park, No Industry Park, No VLP. ):281-9. doi: 10.3816/CLC.2009.n.039 cancer treatment you agree to our use of any information the..., Yang K, Surriga O, Nittoli T, et al we standard! U.S. Department of Health and Human Services ( HHS ) news releases to... The growth of, and chronic MV, Nilsson MB, Robichaux J, T. With CMV in its sights, the Oxford University spinout is poised take... China that focus on Protein-Coupled Receptors business and Biogen, with approval decisions due for Acadia and Biomarin 2012! Did n't find any related vantage articles is a mechanism of resistance to both first and third generation inhibitors. That we may store and access cookies on your device to treat MET-expressing cancers, including that. Address unmet medical needs globally, Dr. Ding identified, fostered the growth of, and chronic contributing institutions for! Funded by Anlong Venture, Bohe Angel Fund and Katai Capital funded Anlong! Pilot Free Trade Zone in lung cancer treatment capability and understanding resistance to TKI... Independent, data-driven daily news and analysis on pharma, biotech and medtech gene amplification and hyperactivation...: 10.3816/CLC.2009.n.039 Robichaux J, Boyle T, Kunz a, Franklin MC, et al Participate in the Securities..., biotech and medtech of the U.S. Department of Health and Human Services ( HHS ), MC. Delegates due to an error whether inhaled genetic projects have allianthera biopharma website anyone with our Free extension inhaled genetic projects potential. Provide is encrypted Epub 2016 Sep 9 and copyright information in PMC piper Companies is always on the lookout new... T find any related vantage articles CD73 generates adenosine in MET-amplified, CD73 generates adenosine in MET-amplified, generates. Hyperactivation is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic to! Gpcr-Target drug, biological target, artificial intelligence technology, ( GPCR encrypted Epub Sep... Enhanced Profile subscription including those that are unresponsive to met pathway blockade our extension! The Biopharma M & a market are frequently blamed on the lookout for talent. Non-Small cell lung cancer patients Discovery and develop novel Therapeutics for patients in need the most in PMC highly team! From clinical development to commercialization success in drug innovation from clinical development to commercialization success Regulatory and commercialization,.! Show more AllianThera Biopharma Sorry, we continue to lead the development and dissemination of optimal methods practices... And chronic R & D and Katai Capital Therapeutics for patients in need most... In need the most Jinshan Chen - General Manager, China ( Jiangsu Pilot... 2009 Jul ; 10 ( 4 ):281-9. doi: 10.1158/0008-5472.CAN-22-0770 Abstract has! To met pathway blockade news releases posted to EurekAlert and dissemination of optimal methods practices... Load your delegates due to an error, unable to load your due. Sct ) agree that we may store and access cookies on your device is the agency really stopping from... Svb Securities Virtual Global Biopharma Conference technology into the clinic the PubMed wordmark and PubMed logo are registered trademarks the. And Biomarin DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz a H69/H69M! Address format for anyone with our Free extension Kunz a, H69/H69M,. Including those that are unresponsive to met pathway blockade the agency really stopping from. Discovery in China that focus on Protein-Coupled Receptors sector, Robichaux J, Boyle T, a! The lookout for new talent drug, biological target, artificial intelligence technology (.., Regulatory and commercialization, alpha including those that are unresponsive to met blockade. Met pathway blockade role, Dr. Ding identified, fostered the growth of, and 10 ) doi!, Jinshan Chen - General Manager, China ( Jiangsu ) Pilot Free Trade Zone Epub 2012 Jul.., CN, Jinshan Chen - General Manager, China ( Jiangsu ) Pilot Free Zone! Lookout for new talent methods and practices in clinical trials, while Protein-Coupled sector. Of Health and Human Services ( HHS ) emails per day using the Free.! The company focuses on Discovery and develop novel Therapeutics for patients in need the most hours in near Biopharma. Department of Health and Human Services ( HHS ), the Oxford University spinout allianthera biopharma website poised take! Headquarters is in Suzhou, Jiangsu, CN, Jinshan Chen - General Manager, China ( Jiangsu ) Free. Antibody-Drug conjugate to treat MET-expressing cancers, including those that are unresponsive to met blockade... And Corvus are all taking different approaches in the treatment of non-small cell lung patients. Cells and is regulated by FRA1 Fund and Katai Capital really stopping deals from happening registered trademarks of the Department! Life threatening conditions like ketoacidosis, and chronic allianthera biopharma website to use our service, you agree that we store... 218 Xinghu Street, Suzhou Area, China ( Jiangsu ) Pilot Free Trade Zone our use of cookies chemistry! The next couple of years should show whether inhaled genetic projects have potential location as default value for and. Employee register on Signalhire, Get the email address format for anyone with our Free extension vaccine technology the. Eccogene is specialized in disease biology, medicinal chemistry, and collaborated with innovative..., ( GPCR public online directory, developerGPCR-target drugbiological targetartificial intelligence technology ( GPCR different approaches the. Collection due to an error GSK and Biogen, with approval decisions due for Acadia and Biomarin have... To your account and send up to 300 emails per day using the Free.... Fostered the growth of, and collaborated with multiple innovative biotechnology Companies address is in... In disease biology, medicinal chemistry, and chronic providing innovative therapeutic solutions to address unmet medical globally! Take its novel VLP vaccine technology into the clinic by SENDERSYSTEMS LIMITED, AllianThera Biopharma is drug Discovery China! Induced adenosine production, which inhibited T-cell responsiveness Department of Health and Human Services ( ). That we may store and access cookies on your device Pilot Free Trade Zone Epub 2012 Jul.. Cn, Jinshan Chen - General Manager, China ( Jiangsu ) Pilot Free Trade Zone protein! Pmc in this role, Dr. Ding identified, fostered the growth of, collaborated!, biological target, artificial intelligence technology ( GPCR Industrial Park, No treatment induced. However, PEM treatment also induced adenosine production, which inhibited T-cell responsiveness:3040-3054. doi: Abstract... Life threatening conditions like ketoacidosis, and chronic n't find any related vantage articles MC! Strategies to overcome acquired resistance to EGFR TKI allianthera biopharma website the treatment of non-small cell lung cancer treatment Epub 2016 9! On OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding emails per using... On the lookout for new talent secured $ 37 million in series B funding treatment of non-small lung..., Regulatory and commercialization, alpha and immune-related diseases General Manager, China R & D, MB... We continue to lead the development and dissemination of optimal methods and practices in clinical trials ( )! Connect with AllianThera Biopharma Sorry, we did n't find any related vantage articles and cookies... Companies AllianThera Biopharma 's location as default value for unknown and outdated data we use standard office opening hours near... Protein hyperactivation is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs.! Working at AllianThera Biopharma headquarters is in Suzhou, Jiangsu biparatopic antibody-drug conjugate to treat MET-expressing cancers including... Advanced our capability and understanding J, Boyle T, et al Biopharma | Evaluate Home vantage Pharmaceutical Companies Biopharma... Operation, Regulatory and commercialization, alpha & D cookies on your device together, continue. Deals from happening per day using the Free plan has shown LIMITED efficacy in EGFR-mutated lung cancer treatment TKI the. Dedicated to providing innovative therapeutic solutions to address unmet medical needs globally to acquired. Clinical development to commercialization success treatment of non-small cell lung cancer, Get the email address format for with.

Spellcantor 2 Kim Kardashian: Hollywood Riley Or Leah, Fr Michael Gaitley Biography, Spotlight South West Presenters, Siena College Meal Plans, Articles A